MDXHEALTH, INC.
IRVINE, CA

Company Overview MDxHealth is a multinational healthcare company that provides actionable epigenetic information to personalize the diagnosis and treatment of cancer. The increased adoption of our ConfirmMDx for Prostate Cancer testing solution within the U.S. urology community has established MDxHealth as a market leader in the important and growing field of cancer epigenetics. Our goal is to build on the success of ConfirmMDx for Prostate Cancer, leveraging our expertise in epigenetics, to establish MDxHealth as the molecular diagnostics  leader in urological oncology. ConfirmMDx has been shown in published studies to distinguish patients who have a true-negative prostate biopsy from those who may have undetected cancer.  With approximately 1 million men receiving an inconclusive biopsy result each year in the U.S., we believe that our ConfirmMDx solution addresses a significant unmet medical need for timely, actionable information that can aid in the reduction of unnecessary repeat biopsies.  We believe that our proprietary, accurate and scalable epigenetic technologies provide MDxHealth with a key competitive advantage in the diagnosis, prognosis and management of cancer.  In addition to our ongoing and planned studies to expand the clinical utility of ConfirmMDx for Prostate Cancer, our product pipeline includes tests for bladder, kidney and other urologic cancers.  For other cancer types, we have engaged partners to commercialize our epigenetic technologies, as shown by the successful launches of Cologuard Why do I need ConfirmMDx? Unfortunately, today’s “gold standard” for diagnosis, the prostate biopsy procedure, only provides a limited evaluation by sampling less than 1% of your entire prostate. Prostate cancer may be present in one or more small tumors, and there is a risk the biopsy needle could have missed it. Your urologist may have concerns about your risk for undetected prostate cancer and recommend ConfirmMDx to determine your need for a repeat biopsy. For more information and to inquire about having the ConfirmMDx for Prostate Cancer test performed, please talk to your doctor. When should I get ConfirmMDx? If you had a negative prostate biopsy within the past 24 months, ask your urologist if ConfirmMDx is right for you. Your doctor can send the remaining tissue samples from your previous prostate biopsy for ConfirmMDx testing. You do not need a repeat biopsy or office visit for this test. For more information and to inquire about having the ConfirmMDx for Prostate Cancer test performed, please talk to your doctor. Does ConfirmMDx require an additional office visit? For more information and to inquire about having the ConfirmMDx for Prostate Cancer test performed, please talk to your doctor. Where is ConfirmMDx performed? Your urologist will submit your previously collected, prostate biopsy samples to MDxHealth for testing in its CAP and CLIA accredited laboratory in Irvine, CA.  The test results will be provided to your urologist. For more information and to inquire about having the ConfirmMDx for Prostate Cancer test performed, please talk to your doctor. Once MDxHealth receives the samples the test will take approximately 7-10 business days until your urologist will receive the test results. For more information and to inquire about having the ConfirmMDx for Prostate Cancer test performed, please talk to your doctor. To receive MDxHealth investor newsletters, please fill in your contact information and click the submit button. MDxHealth Investor Relations Contact info [email protected] To receive MDxHealth investor newsletters, please fill in your contact information and click the submit button.